Basic Fibroblast Growth Factor Predicts Cardiovascular Disease Occurrence in Participants from the Veterans Affairs Diabetes Trial
نویسندگان
چکیده
AIM Cardiovascular disease (CVD) is a leading cause of morbidity and mortality in adults with type 2 diabetes mellitus. The aim of the present study was to test whether plasma basic fibroblast growth factor (bFGF) levels predict future CVD occurrence in adults from the Veterans Affairs Diabetes Trial (VADT). METHODS Nearly 400 veterans, 40 years of age or older having a mean baseline diabetes duration of 11.4 years were recruited from outpatient clinics at six geographically distributed sites in the VADT. Within the VADT, they were randomly assigned to intensive or standard glycemic treatment, with follow-up as much as seven and one-half years. CVD occurrence was examined at baseline in the patient population and during randomized treatment. Plasma bFGF was determined with a sensitive, specific two-site enzyme-linked immunoassay at the baseline study visit in all 399 subjects and repeated at the year 1 study visit in a randomly selected subset of 215 subjects. RESULTS One hundred and five first cardiovascular events occurred in these 399 subjects. The best fit model of risk factors associated with the time to first CVD occurrence (in the study) over a seven and one-half year period had as significant predictors: prior cardiovascular event [hazard ratio (HR) 3.378; 95% confidence intervals (CI) 3.079-3.807; P < 0.0001), baseline plasma bFGF (HR 1.008; 95% CI 1.002-1.014; P = 0.01), age (HR 1.027; 95% CI 1.004-1.051; P = 0.019), baseline plasma triglycerides (HR 1.001; 95% CI 1.000-1.002; P = 0.02), and diabetes duration-treatment interaction (P = 0.03). Intensive glucose-lowering was associated with significantly decreased hazard ratios for CVD occurrence (0.38-0.63) in patients with known diabetes duration of 0-10 years, and non-significantly increased hazard ratios for CVD occurrence (0.82-1.78) in patients with longer diabetes duration. CONCLUSION High level of plasma bFGF is a predictive biomarker of future CVD occurrence in this population of adult type 2 diabetes.
منابع مشابه
بررسی فاکتورهای خطر قلبی عروقی و سندروم متابولیک در جانبازان جنگ با بیماری استرس مزمن ناشی از تروما و گروه شاهد آنها در استان زنجان سال 91-1390
Background and Objective: It seems that war veterans are at increased risk of cardiovascular diseases due to their existing disabilities and special mental and psychological conditions. This study was performed to evaluate the risk of cardiovascular disease and the prevalence of metabolic syndrome among Iran-Iraq war veterans living in Zanjan in 2011. Materials and Methods: 360 men including 12...
متن کاملC-Peptide in insulin resistance and vascular complications: teaching an old dog new tricks.
Clinical Evidence Linking Insulin Resistance, Hyperinsulinemia, and Cardiovascular Disease Based on the recent evidence that patients with type 2 diabetes have the same risk of myocardial infarction as nondiabetic subjects with a history of infarction, diabetes has been designated as an atherosclerosis equivalent.1 Insulin resistance plays a primary role in the development of type 2 diabetes an...
متن کاملBlood Pressure and Cardiovascular Disease Risk in the Veterans Affairs Diabetes Trial
OBJECTIVE Blood pressure ranges associated with cardiovascular disease (CVD) events in advanced type 2 diabetes are not clear. Our objective was to determine whether baseline and follow-up (On-Study) systolic blood pressure (SBP), diastolic blood pressure (DBP), and SBP combined with DBP predict CVD events in the Veterans Affairs Diabetes Trial (VADT). RESEARCH DESIGN AND METHODS Participants...
متن کاملFollow-up of glycemic control and cardiovascular outcomes in type 2 diabetes.
BACKGROUND The Veterans Affairs Diabetes Trial previously showed that intensive glucose lowering, as compared with standard therapy, did not significantly reduce the rate of major cardiovascular events among 1791 military veterans (median follow-up, 5.6 years). We report the extended follow-up of the study participants. METHODS After the conclusion of the clinical trial, we followed participa...
متن کاملIntensive Glucose-Lowering Therapy Reduces Cardiovascular Disease Events in Veterans Affairs Diabetes Trial Participants With Lower Calcified Coronary Atherosclerosis
OBJECTIVE This study investigated the hypothesis that baseline calcified coronary atherosclerosis may determine cardiovascular disease events in response to intensive glycemic control within the Veterans Affairs Diabetes Trial (VADT). RESEARCH DESIGN AND METHODS At baseline, 301 type 2 diabetic participants in the VADT, a randomized trial comparing the effects of intensive versus standard glu...
متن کامل